International Journal of Legal Medicine

, Volume 122, Issue 2, pp 123–128 | Cite as

Kinetics in serum and urinary excretion of ethyl sulfate and ethyl glucuronide after medium dose ethanol intake

  • Claudia C. Halter
  • Sebastian Dresen
  • Volker Auwaerter
  • Friedrich M. Wurst
  • Wolfgang Weinmann
Original Article


The direct ethanol metabolites, ethyl glucuronide (EtG) and ethyl sulfate (EtS), are of increasing importance for clinical and forensic applications, but there are only few studies on the kinetics of EtG in serum and none on EtS. In this study, 13 volunteers (social drinkers) drank ethanol in the form of white wine to reach a blood alcohol concentration of 0.51 ± 0.17 g/kg, and blood and urine samples were analyzed for EtG and EtS simultaneously by chromatography-tandem mass spectrometry (LC-MS/MS). Mean peak serum EtG and EtS concentrations were 2.9 ± 1.3 and 2.8 ± 1.6 μmol/l, respectively, and were reached between 4.0 ± 0.9 h after the start of drinking (3.0 ± 0.5 h for EtS). The mean time differences between reaching maximum blood ethanol levels and serum metabolite levels were 2.3 ± 0.9 h for EtG and 1.2 ± 0.5 h for EtS. In the last blood samples collected (10–11 h after the start of drinking), 11 (of 13) volunteers were still positive for EtG in serum, whereas only 2 were positive for EtS. In the serum of one female person, no EtS was detectable at any time; however, it was excreted in the urine in (low) concentrations. Ethanol was detectable in the serum for up to 8.6 h after the start of drinking, whereas EtG and EtS were detectable up to more than 5.8 h (EtG) and 4.0 h (EtS), respectively. Mean peak urinary concentrations were 401 ± 232 μmol/l for EtG and 266 ± 153 μmol/l for EtS, and mean peak levels were reached 6.2 ± 0.9 h (EtG) and 5.3 ± 1.2 h (EtS) after the start of drinking. Maximum concentrations of EtG and EtS in serum showed a wide interindividual variation and could not be correlated to the maximum blood ethanol concentrations. Correlations (p < 0.001, Kendall’s Tau b) were found when comparing pairs of parameters, but mostly involved areas under the curve (AUC) of metabolites or of ethanol; one correlation linked the peak concentrations of EtG and EtS in urine.


Ethyl glucuronide Ethyl sulfate Ethanol markers Kinetics LC-MS/MS 



The authors wish to thank the “Bund gegen Alkohol und Drogen im Straßenverkehr e.V.” for the funding of the study.

Supplementary material


  1. 1.
    Barbour AD (2001) Simplified estimation of Widmark “r” values by the method of Forrest. Sci Justice 41:53–54PubMedCrossRefGoogle Scholar
  2. 2.
    UGT Alleles Nomenclature Home Page. UGT Nomenclature Committee. June 2005. [21.03.2007].
  3. 3.
    Dresen S, Weinmann W, Wurst FM (2004) Forensic confirmatory analysis of ethyl sulfate—a new marker for alcohol consumption—by liquid-chromatography/electrospray ionization/tandem mass spectrometry. J Am Soc Mass Spectrom 15:1644–1648PubMedCrossRefGoogle Scholar
  4. 4.
    Droenner P, Schmitt G, Aderjan R, Zimmer H (2002) A kinetic model describing the pharmacokinetics of ethyl glucuronide in humans. Forensic Sci Int 126:24–29PubMedCrossRefGoogle Scholar
  5. 5.
    Foti RS, Fisher MB (2005) Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs. Forensic Sci Int 153:109–116PubMedCrossRefGoogle Scholar
  6. 6.
    Helander A, Beck O (2004) Mass spectrometric identification of ethyl sulfate as an ethanol metabolite in humans. Clin Chem 50:936–937PubMedCrossRefGoogle Scholar
  7. 7.
    Helander A, Dahl H (2005) Urinary tract infection: a risk factor for false-negative urinary ethyl glucuronide but not ethyl sulfate in the detection of recent alcohol consumption. Clin Chem 51:1728–1730PubMedCrossRefGoogle Scholar
  8. 8.
    Kardon T, Coffey MJ, Banhegyi G, Conley AA, Burchell B, Mandl J, Braun L (2000) Transcriptional induction of bilirubin UDP-glucuronosyltransrase by ethanol in rat liver. Alcohol 21:251–257PubMedCrossRefGoogle Scholar
  9. 9.
    Nash RM, Stein L, Penno MB, Passananti GT, Vesell ES (1984) Sources of interindividual variations in acetaminophen and antipyrine metabolism. Clin Pharmacol Ther 36:417–430PubMedCrossRefGoogle Scholar
  10. 10.
    Politi L, Morini L, Groppi A, Poloni V, Pozzi F, Polettini A (2005) Direct determination of the ethanol metabolites ethyl glucuronide and ethyl sulfate in urine by liquid chromatography/electrospray tandem mass spectrometry. Rapid Comm Mass Spectrom 19:1321–1331CrossRefGoogle Scholar
  11. 11.
    Schloegl H, Dresen S, Spaczynski K, Stoertzel M, Wurst FM, Weinmann W (2006) Stability of ethyl glucuronide in urine, post-mortem tissue and blood samples. Int J Legal Med 120:83–88PubMedCrossRefGoogle Scholar
  12. 12.
    Schneider H, Glatt H (2004) Sulpho-conjugation of ethanol in humans in vivo and by individual sulphotransferase forms in vitro. Biochem J 383:543–549PubMedCrossRefGoogle Scholar
  13. 13.
    Thomae BA, Rifki OF, Theobald MA, Eckloff BW, Wieben ED, Weinshilboum RM (2003) Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: functional genetic polymorphism. J Neurochem 87:809–819PubMedCrossRefGoogle Scholar
  14. 14.
    Weinmann W, Schaefer P, Thierauf A, Schreiber A, Wurst FM (2004) Confirmatory analysis of ethylglucuronide in urine by liquid-chromatography/electrospray ionization/tandem mass spectrometry according to forensic guidelines. J Am Soc Mass Spectrom 15:188–193PubMedCrossRefGoogle Scholar
  15. 15.
    Wurst FM, Metzger J (2002) The ethanol conjugate ethyl glucuronide is a useful marker of recent alcohol consumption. Alcohol Clin Exp Res 26:1114–1119PubMedCrossRefGoogle Scholar
  16. 16.
    Wurst FM, Skipper GE, Weinmann W (2003) Ethyl glucuronide—the direct ethanol metabolite on the threshold from science to routine use. Addiction 98(Suppl 2):51–61PubMedCrossRefGoogle Scholar
  17. 17.
    Wurst FM, Wiesbeck GA, Metzger JW, Weinmann W (2004) On sensitivity, specificity, and the influence of various parameters on ethyl glucuronide levels in urine—results from the WHO/ISBRA study. Alcohol Clin Exp Res 28:1220–1228PubMedCrossRefGoogle Scholar
  18. 18.
    Wurst FM, Alling C, Aradottir S et al (2005) Emerging biomarkers: new directions and clinical applications. Alcohol Clin Exp Res 29:465–473PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Claudia C. Halter
    • 1
  • Sebastian Dresen
    • 1
  • Volker Auwaerter
    • 1
  • Friedrich M. Wurst
    • 2
  • Wolfgang Weinmann
    • 1
  1. 1.Institute of Forensic MedicineUniversity Hospital FreiburgFreiburgGermany
  2. 2.Psychiatric University ClinicBaselSwitzerland

Personalised recommendations